TY - JOUR
T1 - Detection of astrocytic tau pathology facilitates recognition of chronic traumatic encephalopathy neuropathologic change
AU - CONNECT-TBI Investigators
AU - Ameen-Ali, Kamar E.
AU - Bretzin, Abigail
AU - Lee, Edward B.
AU - Folkerth, Rebecca
AU - Hazrati, Lili Naz
AU - Iacono, Diego
AU - Keene, C. Dirk
AU - Kofler, Julia
AU - Kovacs, Gabor G.
AU - Nolan, Amber
AU - Perl, Daniel P.
AU - Priemer, David S.
AU - Smith, Douglas H.
AU - Wiebe, Douglas J.
AU - Stewart, William
AU - Al-Sarraj, Safa
AU - Cortes, Etty
AU - Crary, John
AU - Dams-O’Connor, Kristin
AU - Diaz-Arrastia, Ramon
AU - Dollé, Jean Pierre
AU - Edlow, Brian
AU - Fischl, Bruce
AU - Hinds, Col Sidney
AU - Johnson, Victoria E.
AU - Manley, Geoffrey
AU - Meaney, David
AU - Okonkwo, David
AU - Schneider, Andrea L.C.
AU - Schneider, Julie
AU - Troakes, Claire
AU - Trojanowski, John Q.
AU - van der Kouwe, Andre
AU - Yaffe, Kristine
N1 - Funding Information:
This work was supported by funding from: the National Institutes of Health, National Institute of Neurologic Disorders and Stroke, US (award numbers U54NS115322, R01NS03814); the National Institutes on Aging, US (award numbers P30AG072979, P01AG066597); and the Nancy and Buster Alvord Endowment.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Traumatic brain injury (TBI) is associated with the development of a range of neurodegenerative pathologies, including chronic traumatic encephalopathy (CTE). Current consensus diagnostic criteria define the pathognomonic cortical lesion of CTE neuropathologic change (CTE-NC) as a patchy deposition of hyperphosphorylated tau in neurons, with or without glial tau in thorn-shaped astrocytes, typically towards the depths of sulci and clustered around small blood vessels. Nevertheless, although incorporated into consensus diagnostic criteria, the contribution of the individual cellular components to identification of CTE-NC has not been formally evaluated. To address this, from the Glasgow TBI Archive, cortical tissue blocks were selected from consecutive brain donations from contact sports athletes in which there was known to be either CTE-NC (n = 12) or Alzheimer’s disease neuropathologic change (n = 4). From these tissue blocks, adjacent tissue sections were stained for tau antibodies selected to reveal either solely neuronal pathology (3R tau; GT-38) or mixed neuronal and astroglial pathologies (4R tau; PHF-1). These stained sections were then randomised and independently assessed by a panel of expert neuropathologists, blind to patient clinical history and primary antibody applied to each section, who were asked to record whether CTE-NC was present. Results demonstrate that, in sections stained for either 4R tau or PHF-1, consensus recognition of CTE-NC was high. In contrast, recognition of CTE-NC in sections stained for 3R tau or GT-38 was poor; in the former no better than chance. Our observations demonstrate that the presence of both neuronal and astroglial tau pathologies facilitates detection of CTE-NC, with its detection less consistent when neuronal tau pathology alone is visible. The combination of both glial and neuronal pathologies, therefore, may be required for detection of CTE-NC.
AB - Traumatic brain injury (TBI) is associated with the development of a range of neurodegenerative pathologies, including chronic traumatic encephalopathy (CTE). Current consensus diagnostic criteria define the pathognomonic cortical lesion of CTE neuropathologic change (CTE-NC) as a patchy deposition of hyperphosphorylated tau in neurons, with or without glial tau in thorn-shaped astrocytes, typically towards the depths of sulci and clustered around small blood vessels. Nevertheless, although incorporated into consensus diagnostic criteria, the contribution of the individual cellular components to identification of CTE-NC has not been formally evaluated. To address this, from the Glasgow TBI Archive, cortical tissue blocks were selected from consecutive brain donations from contact sports athletes in which there was known to be either CTE-NC (n = 12) or Alzheimer’s disease neuropathologic change (n = 4). From these tissue blocks, adjacent tissue sections were stained for tau antibodies selected to reveal either solely neuronal pathology (3R tau; GT-38) or mixed neuronal and astroglial pathologies (4R tau; PHF-1). These stained sections were then randomised and independently assessed by a panel of expert neuropathologists, blind to patient clinical history and primary antibody applied to each section, who were asked to record whether CTE-NC was present. Results demonstrate that, in sections stained for either 4R tau or PHF-1, consensus recognition of CTE-NC was high. In contrast, recognition of CTE-NC in sections stained for 3R tau or GT-38 was poor; in the former no better than chance. Our observations demonstrate that the presence of both neuronal and astroglial tau pathologies facilitates detection of CTE-NC, with its detection less consistent when neuronal tau pathology alone is visible. The combination of both glial and neuronal pathologies, therefore, may be required for detection of CTE-NC.
KW - Aging-related tau astrogliopathy
KW - Chronic traumatic encephalopathy
KW - Neurodegeneration
KW - Tau
KW - Traumatic brain injury
UR - http://www.scopus.com/inward/record.url?scp=85128043885&partnerID=8YFLogxK
U2 - 10.1186/s40478-022-01353-4
DO - 10.1186/s40478-022-01353-4
M3 - Article
C2 - 35410438
AN - SCOPUS:85128043885
SN - 2051-5960
VL - 10
JO - Acta neuropathologica communications
JF - Acta neuropathologica communications
IS - 1
M1 - 50
ER -